semaglutide and cardiovascular outcomes in diabetes Patients with Type 2 Insights into semaglutide cardiovascular research:

Veterinary trials assess Ozempic-style weight loss drugs for cats, with early safety goals, dose focus, and obesity risk context.

Stunkard Professor and former Director of the Center for Weight and Eating Disorders at the University of Pennsylvania School of Medicine

And what they started reporting didn't always match what the clinical trials described

Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says.

SEMA ameliorated the TAA-induced oxidative stress by mitigating the derangement in nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, reducing glutathione (GSH) levels, and decreasing malondialdehyde (MDA) levels